Urological Malignancies Programme Lead Professor Grant Stewart has authored a seminal review for The Lancet medical journal in which he and his international co-authors (including Professor Evis Sala and Mr Ben Lamb from Cambridge) lay out the current best multi-speciality practice for the management of localised kidney cancer, while underlining areas currently in need of further research and development.
The review highlights developments in the treatment of kidney cancer over the past two decades, with the transition away from a siloed single-speciality means of treatment, whereby urological surgeons managed the localised stages of the disease and medical oncologists cared for patients if metastases developed, to a multi-speciality based approach.
Professor Stewart said: "'I am delighted that members of our multi-speciality, kidney cancer team from Cambridge led this paper published in The Lancet, which will become the key review in the field of localised kidney cancer. The paper encapsulates the Cambridge ethos around the modern management of this often silent and frequently lethal disease."
The review celebrates the greater understanding of the disease biology, diagnostic options, and innovations in curative treatments that have occurred over the last two decades.
The authors also acknowledge the increasingly more complex landscape for patients and clinicians to navigate now that such changes have been introduced. Such an outlook necessitates multiple skillsets and the evolution of a multi-speciality approach to the management of kidney cancer.
Reference
Stewart G D et al The multispeciality approach to the management of localised kidney cancer The Lancet July 2022 https://doi.org/10.1016/S0140-6736(22)01059-5
